Indonesia Suspends Use of AstraZeneca CTMAV547 Batch after Death of 22-Year-Old

Indonesia has now suspended the distribution of a batch of AstraZeneca’s Covid-19 vaccines following the death of a 22-year-old a day after he took the jab, on Sunday.

The health ministry has suspended the distribution of the CTMAV547 batch with nearly 450,000 doses, which will be subject to toxicity and sterility tests by the Food and Drug Administration (BPOM) to ensure its safety.

Health ministry official Widyawati said, “Not all of the AstraZeneca vaccine batches distribution and use were suspended. Only Batch CTMAV547 was temporarily suspended pending the results of investigations and testing from BPOM, which may take one to two weeks.”

Widyawati also said that other AstraZeneca batches are still safe to receive.

Indonesia procured the CTMAV547 batch through the World Health Organization’s global COVAX facility.

The 22-year-old Trio Fauki Firdaus died a day after he received the vaccine on May 5 in East Jakarta, the Jakarta Globe reported.

Firdaus experienced headaches, fever and muscle pain when he arrived home, and was later admitted to the hospital the next day but died before doctors could treat him.

© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.